ImmunoCellular Therapeutics, Ltd. License Agreements
11 Contracts & Agreements
- CONFIDENTIAL SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 9, 2015)
- CONFIDENTIAL AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 7, 2015)
- CLIENT LICENSE AGREEMENT AMENDMENT (Filed With SEC on August 14, 2012)
- Text Marked By [* * *] Has Been Omitted Pursuant To A Request For Confidential Treatment And Was Filed Separately With The Securities And Exchange Commission. EXCLUSIVE LICENSE... (Filed With SEC on March 21, 2012)
- CLIENT LICENSE AGREEMENT AMENDMENT (Filed With SEC on August 18, 2011)
- AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 18, 2010)
- SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 13, 2009)
- FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 14, 2008)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 22, 2006)
- TO ASSIGNMENT AND LICENSE AGREEMENT (Filed With SEC on February 6, 2006)
- TO ASSIGNMENT AND LICENSE AGREEMENT (Filed With SEC on February 6, 2006)
